Nanthaya Tisavipat, Hadas Stiebel-Kalish, Dahlia Palevski, Omer Y Bialer, Heather E Moss, Pareena Chaitanuwong, Tanyatuth Padungkiatsagul, Amanda D Henderson, Elias S Sotirchos, Shonar Singh, Abdul-Rahman Salman, Deena A Tajfirouz, Kevin D Chodnicki, Sean J Pittock, Eoin P Flanagan, John J Chen
{"title":"老年人急性视神经病变:区分 MOGAD 视神经炎和非动脉炎性前部缺血性视神经病变。","authors":"Nanthaya Tisavipat, Hadas Stiebel-Kalish, Dahlia Palevski, Omer Y Bialer, Heather E Moss, Pareena Chaitanuwong, Tanyatuth Padungkiatsagul, Amanda D Henderson, Elias S Sotirchos, Shonar Singh, Abdul-Rahman Salman, Deena A Tajfirouz, Kevin D Chodnicki, Sean J Pittock, Eoin P Flanagan, John J Chen","doi":"10.1212/NXI.0000000000200214","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Myelin oligodendrocyte glycoprotein antibody-associated disease optic neuritis (MOGAD-ON) and nonarteritic anterior ischemic optic neuropathy (NAION) can cause acute optic neuropathy in older adults but have different managements. We aimed to determine differentiating factors between MOGAD-ON and NAION and the frequency of serum MOG-IgG false positivity among patients with NAION.</p><p><strong>Methods: </strong>In this international, multicenter, case-control study at tertiary neuro-ophthalmology centers, patients with MOGAD presenting with unilateral optic neuritis as their first attack at age 45 years or older and age-matched and sex-matched patients with NAION were included. Comorbidities, clinical presentations, acute optic disc findings, optical coherence tomography (OCT) findings, and outcomes were compared between MOGAD-ON and NAION. Multivariate analysis was performed to find statistically significant predictors of MOGAD-ON. A separate review of consecutive NAION patients seen at Mayo Clinic, Rochester, from 2018 to 2022, was conducted to estimate the frequency of false-positive MOG-IgG in this population.</p><p><strong>Results: </strong>Sixty-four patients with unilateral MOGAD-ON were compared with 64 patients with NAION. Among patients with MOGAD-ON, the median age at onset was 56 (interquartile range [IQR] 50-61) years, 70% were female, and 78% were White. Multivariate analysis showed that eye pain was strongly associated with MOGAD-ON (OR 32.905; 95% CI 2.299-473.181), while crowded optic disc (OR 0.033; 95% CI 0.002-0.492) and altitudinal visual field defect (OR 0.028; 95% CI 0.002-0.521) were strongly associated with NAION. On OCT, peripapillary retinal nerve fiber layer (pRNFL) thickness in unilateral MOGAD-ON was lower than in NAION (median 114 vs 201 μm, <i>p</i> < 0.001; median pRNFL thickening 25 vs 102 μm, <i>p</i> < 0.001). MOGAD-ON had more severe vision loss at nadir (median logMAR 1.0 vs 0.3, <i>p</i> < 0.001), but better recovery (median logMAR 0.1 vs 0.3, <i>p</i> = 0.002). In the cohort of consecutive NAION patients, 66/212 (31%) patients with NAION were tested for MOG-IgG and 8% (95% CI 1%-14%) of those had false-positive serum MOG-IgG at low titers.</p><p><strong>Discussion: </strong>Acute unilateral optic neuropathy with optic disc edema in older adults can be caused by either MOGAD-ON or NAION. Detailed history, the degree of pRNFL swelling on OCT, and visual outcomes can help differentiate the entities and prevent indiscriminate serum MOG-IgG testing in all patients with acute optic neuropathy.</p>","PeriodicalId":19472,"journal":{"name":"Neurology® Neuroimmunology & Neuroinflammation","volume":null,"pages":null},"PeriodicalIF":7.8000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11073893/pdf/","citationCount":"0","resultStr":"{\"title\":\"Acute Optic Neuropathy in Older Adults: Differentiating Between MOGAD Optic Neuritis and Nonarteritic Anterior Ischemic Optic Neuropathy.\",\"authors\":\"Nanthaya Tisavipat, Hadas Stiebel-Kalish, Dahlia Palevski, Omer Y Bialer, Heather E Moss, Pareena Chaitanuwong, Tanyatuth Padungkiatsagul, Amanda D Henderson, Elias S Sotirchos, Shonar Singh, Abdul-Rahman Salman, Deena A Tajfirouz, Kevin D Chodnicki, Sean J Pittock, Eoin P Flanagan, John J Chen\",\"doi\":\"10.1212/NXI.0000000000200214\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objectives: </strong>Myelin oligodendrocyte glycoprotein antibody-associated disease optic neuritis (MOGAD-ON) and nonarteritic anterior ischemic optic neuropathy (NAION) can cause acute optic neuropathy in older adults but have different managements. We aimed to determine differentiating factors between MOGAD-ON and NAION and the frequency of serum MOG-IgG false positivity among patients with NAION.</p><p><strong>Methods: </strong>In this international, multicenter, case-control study at tertiary neuro-ophthalmology centers, patients with MOGAD presenting with unilateral optic neuritis as their first attack at age 45 years or older and age-matched and sex-matched patients with NAION were included. Comorbidities, clinical presentations, acute optic disc findings, optical coherence tomography (OCT) findings, and outcomes were compared between MOGAD-ON and NAION. Multivariate analysis was performed to find statistically significant predictors of MOGAD-ON. A separate review of consecutive NAION patients seen at Mayo Clinic, Rochester, from 2018 to 2022, was conducted to estimate the frequency of false-positive MOG-IgG in this population.</p><p><strong>Results: </strong>Sixty-four patients with unilateral MOGAD-ON were compared with 64 patients with NAION. Among patients with MOGAD-ON, the median age at onset was 56 (interquartile range [IQR] 50-61) years, 70% were female, and 78% were White. Multivariate analysis showed that eye pain was strongly associated with MOGAD-ON (OR 32.905; 95% CI 2.299-473.181), while crowded optic disc (OR 0.033; 95% CI 0.002-0.492) and altitudinal visual field defect (OR 0.028; 95% CI 0.002-0.521) were strongly associated with NAION. On OCT, peripapillary retinal nerve fiber layer (pRNFL) thickness in unilateral MOGAD-ON was lower than in NAION (median 114 vs 201 μm, <i>p</i> < 0.001; median pRNFL thickening 25 vs 102 μm, <i>p</i> < 0.001). MOGAD-ON had more severe vision loss at nadir (median logMAR 1.0 vs 0.3, <i>p</i> < 0.001), but better recovery (median logMAR 0.1 vs 0.3, <i>p</i> = 0.002). In the cohort of consecutive NAION patients, 66/212 (31%) patients with NAION were tested for MOG-IgG and 8% (95% CI 1%-14%) of those had false-positive serum MOG-IgG at low titers.</p><p><strong>Discussion: </strong>Acute unilateral optic neuropathy with optic disc edema in older adults can be caused by either MOGAD-ON or NAION. Detailed history, the degree of pRNFL swelling on OCT, and visual outcomes can help differentiate the entities and prevent indiscriminate serum MOG-IgG testing in all patients with acute optic neuropathy.</p>\",\"PeriodicalId\":19472,\"journal\":{\"name\":\"Neurology® Neuroimmunology & Neuroinflammation\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":7.8000,\"publicationDate\":\"2024-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11073893/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neurology® Neuroimmunology & Neuroinflammation\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1212/NXI.0000000000200214\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/3/28 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology® Neuroimmunology & Neuroinflammation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1212/NXI.0000000000200214","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/28 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景和目的:髓鞘少突胶质细胞糖蛋白抗体相关疾病视神经炎(MOGAD-ON)和非动脉炎性前部缺血性视神经病变(NAION)可导致老年人急性视神经病变,但治疗方法不同。我们旨在确定区分 MOGAD-ON 和 NAION 的因素,以及 NAION 患者血清 MOG-IgG 假阳性的频率:在这项国际多中心病例对照研究中,我们在三级神经眼科中心纳入了首次发病为单侧视神经炎、年龄在 45 岁或以上的 MOGAD 患者,以及年龄和性别匹配的 NAION 患者。比较了 MOGAD-ON 和 NAION 患者的并发症、临床表现、急性视盘发现、光学相干断层扫描 (OCT) 发现和预后。进行了多变量分析,以发现对 MOGAD-ON 有统计学意义的预测因素。对2018年至2022年在罗切斯特梅奥诊所就诊的连续NAION患者进行了单独回顾,以估计该人群中MOG-IgG假阳性的频率:64名单侧MOGAD-ON患者与64名NAION患者进行了比较。在MOGAD-ON患者中,发病年龄中位数为56岁(四分位数间距[IQR]50-61),70%为女性,78%为白人。多变量分析表明,眼痛与MOGAD-ON密切相关(OR 32.905;95% CI 2.299-473.181),而拥挤的视盘(OR 0.033;95% CI 0.002-0.492)和高度视野缺损(OR 0.028;95% CI 0.002-0.521)与NAION密切相关。在 OCT 上,单侧 MOGAD-ON 的毛细血管周围视网膜神经纤维层(pRNFL)厚度低于 NAION(中位数 114 vs 201 μm,p < 0.001;中位数 pRNFL 增厚 25 vs 102 μm,p < 0.001)。MOGAD-ON 患者的视力在最低点时下降更严重(中位数 logMAR 1.0 vs 0.3,p < 0.001),但恢复得更好(中位数 logMAR 0.1 vs 0.3,p = 0.002)。在连续NAION患者队列中,66/212(31%)名NAION患者接受了MOG-IgG检测,其中8%(95% CI 1%-14% )的低滴度血清MOG-IgG呈假阳性:讨论:老年人急性单侧视神经病变伴视盘水肿可由MOGAD-ON或NAION引起。详细的病史、OCT 显示的 pRNFL 肿胀程度和视觉结果有助于区分这两种疾病,避免对所有急性视神经病变患者不加区分地进行血清 MOG-IgG 检测。
Acute Optic Neuropathy in Older Adults: Differentiating Between MOGAD Optic Neuritis and Nonarteritic Anterior Ischemic Optic Neuropathy.
Background and objectives: Myelin oligodendrocyte glycoprotein antibody-associated disease optic neuritis (MOGAD-ON) and nonarteritic anterior ischemic optic neuropathy (NAION) can cause acute optic neuropathy in older adults but have different managements. We aimed to determine differentiating factors between MOGAD-ON and NAION and the frequency of serum MOG-IgG false positivity among patients with NAION.
Methods: In this international, multicenter, case-control study at tertiary neuro-ophthalmology centers, patients with MOGAD presenting with unilateral optic neuritis as their first attack at age 45 years or older and age-matched and sex-matched patients with NAION were included. Comorbidities, clinical presentations, acute optic disc findings, optical coherence tomography (OCT) findings, and outcomes were compared between MOGAD-ON and NAION. Multivariate analysis was performed to find statistically significant predictors of MOGAD-ON. A separate review of consecutive NAION patients seen at Mayo Clinic, Rochester, from 2018 to 2022, was conducted to estimate the frequency of false-positive MOG-IgG in this population.
Results: Sixty-four patients with unilateral MOGAD-ON were compared with 64 patients with NAION. Among patients with MOGAD-ON, the median age at onset was 56 (interquartile range [IQR] 50-61) years, 70% were female, and 78% were White. Multivariate analysis showed that eye pain was strongly associated with MOGAD-ON (OR 32.905; 95% CI 2.299-473.181), while crowded optic disc (OR 0.033; 95% CI 0.002-0.492) and altitudinal visual field defect (OR 0.028; 95% CI 0.002-0.521) were strongly associated with NAION. On OCT, peripapillary retinal nerve fiber layer (pRNFL) thickness in unilateral MOGAD-ON was lower than in NAION (median 114 vs 201 μm, p < 0.001; median pRNFL thickening 25 vs 102 μm, p < 0.001). MOGAD-ON had more severe vision loss at nadir (median logMAR 1.0 vs 0.3, p < 0.001), but better recovery (median logMAR 0.1 vs 0.3, p = 0.002). In the cohort of consecutive NAION patients, 66/212 (31%) patients with NAION were tested for MOG-IgG and 8% (95% CI 1%-14%) of those had false-positive serum MOG-IgG at low titers.
Discussion: Acute unilateral optic neuropathy with optic disc edema in older adults can be caused by either MOGAD-ON or NAION. Detailed history, the degree of pRNFL swelling on OCT, and visual outcomes can help differentiate the entities and prevent indiscriminate serum MOG-IgG testing in all patients with acute optic neuropathy.
期刊介绍:
Neurology Neuroimmunology & Neuroinflammation is an official journal of the American Academy of Neurology. Neurology: Neuroimmunology & Neuroinflammation will be the premier peer-reviewed journal in neuroimmunology and neuroinflammation. This journal publishes rigorously peer-reviewed open-access reports of original research and in-depth reviews of topics in neuroimmunology & neuroinflammation, affecting the full range of neurologic diseases including (but not limited to) Alzheimer's disease, Parkinson's disease, ALS, tauopathy, and stroke; multiple sclerosis and NMO; inflammatory peripheral nerve and muscle disease, Guillain-Barré and myasthenia gravis; nervous system infection; paraneoplastic syndromes, noninfectious encephalitides and other antibody-mediated disorders; and psychiatric and neurodevelopmental disorders. Clinical trials, instructive case reports, and small case series will also be featured.